John B Wong
#117,262
Most Influential Person Now
Researcher
John B Wong's AcademicInfluence.com Rankings
John B Wongengineering Degrees
Engineering
#3597
World Rank
#4699
Historical Rank
Electrical Engineering
#822
World Rank
#890
Historical Rank
John B Wongcomputer-science Degrees
Computer Science
#4615
World Rank
#4868
Historical Rank
Computational Linguistics
#478
World Rank
#486
Historical Rank
Machine Learning
#962
World Rank
#976
Historical Rank
Artificial Intelligence
#1182
World Rank
#1203
Historical Rank
Download Badge
Engineering Computer Science
John B Wong's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is John B Wong Influential?
(Suggest an Edit or Addition)John B Wong's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs (2010) (4048)
- Incidence and Economic Burden of Osteoporosis‐Related Fractures in the United States, 2005–2025 (2007) (3362)
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance (2018) (2204)
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update (2013) (1711)
- Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. (2005) (1566)
- Effect of Vitamin D on falls: a meta-analysis. (2004) (1386)
- Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials (2009) (1292)
- Early virologic response to treatment with peginterferon alfa‐2b plus ribavirin in patients with chronic hepatitis C (2003) (876)
- Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. (2009) (835)
- Effect of failed extubation on the outcome of mechanical ventilation. (1997) (759)
- Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement (2018) (720)
- Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7. (2012) (624)
- Estimating future hepatitis C morbidity, mortality, and costs in the United States. (2000) (607)
- Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. (2021) (504)
- Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. (2018) (457)
- A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. (2003) (454)
- Meta-analysis: The Effect of Dietary Counseling for Weight Loss (2007) (451)
- Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta‐analysis (2016) (390)
- Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. (2007) (351)
- The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. (1997) (333)
- Comparative Effectiveness of Pharmacologic Interventions for Knee Osteoarthritis (2015) (313)
- Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement (2018) (301)
- Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. (2021) (300)
- A Systematic Review of Stakeholder Engagement in Comparative Effectiveness and Patient-Centered Outcomes Research (2014) (296)
- Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES) (2016) (283)
- Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta‐analysis (2016) (260)
- Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: US Preventive Services Task Force Recommendation Statement (2018) (259)
- Model Transparency and Validation (2012) (255)
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement. (2019) (253)
- A guide for surveillance of patients with Barrett's esophagus. (1994) (252)
- Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis. (1995) (248)
- Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk (1999) (247)
- Patient-specific decisions about hormone replacement therapy in postmenopausal women. (1997) (242)
- Interventions to Prevent Perinatal Depression: US Preventive Services Task Force Recommendation Statement (2019) (241)
- Foot infections in diabetic patients. Decision and cost-effectiveness analyses. (1995) (240)
- ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Societ (2014) (223)
- Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement (2018) (221)
- Cost-effectiveness of Interferon-2b Treatment for Hepatitis B e Antigen-Positive Chronic Hepatitis B (1995) (218)
- Decision making in health and medicine: Integrating evidence and values, second edition (2014) (209)
- Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands. (2007) (202)
- Myocardial revascularization for chronic stable angina. Analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989. (1990) (197)
- Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C (2003) (197)
- Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement. (2019) (193)
- Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs. (1998) (189)
- Screening for Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: US Preventive Services Task Force Final Recommendation Statement (2018) (184)
- Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement. (2019) (176)
- ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Impr (2011) (174)
- Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial (2015) (170)
- Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States (2007) (167)
- Watchful Waiting with Periodic Liver Biopsy versus Immediate Empirical Therapy for Histologically Mild Chronic Hepatitis C: A Cost-Effectiveness Analysis (2000) (167)
- Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis (2010) (164)
- Hepatitis C Guidance 2019 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. (2019) (158)
- Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. (2020) (156)
- Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement. (2020) (150)
- ACCF/AHA/AMA-PCPI 2011 Performance Measures for Adults With Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association–Physician Consortium for Performance Improvement (2012) (148)
- Hormone replacement therapy after breast cancer: a systematic review and quantitative assessment of risk. (2001) (143)
- Systematic review of outcomes after surgical management of venous disease incorporating subfascial endoscopic perforator surgery. (2004) (143)
- Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement. (2021) (142)
- Long-term morbidity, mortality, and economics of rheumatoid arthritis. (2001) (141)
- Estimating the proportion of patients infected with HIV who will die of comorbid diseases. (2005) (141)
- Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis. (2002) (140)
- Screening for Abdominal Aortic Aneurysm: US Preventive Services Task Force Recommendation Statement. (2019) (140)
- Milk intake and risk of hip fracture in men and women: A meta‐analysis of prospective cohort studies (2011) (140)
- Epilepsy surgery for pharmacoresistant temporal lobe epilepsy: a decision analysis. (2008) (139)
- Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms. (2008) (139)
- Effectiveness and Implications of Alternative Placebo Treatments (2015) (136)
- Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance (2018) (133)
- Screening for Atrial Fibrillation With Electrocardiography: US Preventive Services Task Force Recommendation Statement (2018) (130)
- Interferon and ribavirin for patients with chronic hepatitis C who did not respond to previous interferon therapy: A meta‐analysis of controlled and uncontrolled trials (2001) (125)
- Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. (1999) (123)
- Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: A decision analysis (2004) (116)
- Treatment of early Lyme disease. (1992) (114)
- Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta‐analysis (2017) (113)
- Screening for HIV Infection: US Preventive Services Task Force Recommendation Statement. (2019) (112)
- Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors: US Preventive Services Task Force Recommendation Statement (2018) (112)
- Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C. (2003) (111)
- Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis (2012) (110)
- Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis. (1995) (110)
- LIVING-DONOR VERSUS CADAVERIC LIVER TRANSPLANTATION FOR NON-RESECTABLE SMALL HEPATOCELLULAR CARCINOMA AND COMPENSATED CIRRHOSIS: A DECISION ANALYSIS1 (2001) (106)
- Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement. (2021) (104)
- Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001–2002 (2006) (102)
- Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective. (1990) (101)
- Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk. (1999) (99)
- Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement. (2019) (95)
- Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index: US Preventive Services Task Force Recommendation Statement (2018) (92)
- Empirical Anti-Candida Therapy among Selected Patients in the Intensive Care Unit: A Cost-Effectiveness Analysis (2005) (92)
- Cost-effectiveness of 24 or 48 weeks of interferon alpha-2b alone or with ribavirin as initial treatment of chronic hepatitis C. International Hepatitis Interventional Therapy Group. (2000) (92)
- Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy. (2002) (88)
- Screening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation Statement (2018) (86)
- Toward a Peer Review Process for Medical Decision Analysis Models (1994) (84)
- Strategies for Managing Anemia in Hepatitis C Patients Undergoing Antiviral Therapy (2007) (84)
- Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: US Preventive Services Task Force Recommendation Statement. (2020) (83)
- Screening for Unhealthy Drug Use: US Preventive Services Task Force Recommendation Statement. (2020) (82)
- Cost-effectiveness of 24 or 48 weeks of interferon α-2b alone or with ribavirin as initial treatment of chronic hepatitis c (2000) (80)
- Discussing Conservative Management With Older Patients With CKD: An Interview Study of Nephrologists. (2018) (80)
- Electrocardiogram Screening for Disorders That Cause Sudden Cardiac Death in Asymptomatic Children: A Meta-analysis (2012) (78)
- Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy (2015) (78)
- ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. (2012) (77)
- Predicting the probability of progression‐free survival in patients with small hepatocellular carcinoma (2002) (75)
- Cost-effectiveness of combination therapy for naive patients with chronic hepatitis C. (2000) (72)
- Cost-effectiveness of streptokinase for acute myocardial infarction: A combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction. (1994) (71)
- Screening for acquired cystic kidney disease: a decision analytic perspective. (1995) (70)
- Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis (1998) (70)
- Comparative Effectiveness of Tai Chi Versus Physical Therapy for Knee Osteoarthritis (2016) (70)
- Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration. (2013) (69)
- Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta‐analysis (2016) (68)
- Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement. (2021) (67)
- ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for Multimodality Imaging in Valvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society (2018) (66)
- Comparing the public health burden of chronic hepatitis C and HIV infection in France. (2004) (66)
- Detecting acute cardiac ischemia in the emergency department (1990) (65)
- Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement. (2022) (65)
- Neonatal screening for sickle cell disease: a cost-effectiveness analysis. (1991) (64)
- ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thor (2012) (64)
- A Survey of Current Problems in Meta‐Analysis: Discussion from the Agency for Health Care Policy and Research Inter‐PORT Work Group on Literature Review/Meta‐Analysis (1995) (63)
- Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement. (2021) (62)
- ACCF 2012 health policy statement on patient-centered care in cardiovascular medicine: a report of the American College of Cardiology Foundation Clinical Quality Committee. (2012) (62)
- Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis. (2004) (62)
- Cost‐effectiveness of Radiofrequency Ablation Compared With Other Strategies in Wolff‐Parkinson‐White Syndrome (1993) (61)
- Economic and clinical effects of evaluating rapid viral response to peginterferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C (2003) (60)
- Putting Families in the Center (2012) (60)
- Screening for Syphilis Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement (2018) (59)
- Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies. (2006) (58)
- Costs and Benefits of Targeted Screening for Causes of Sudden Cardiac Death in Children and Adolescents (2012) (58)
- Comparative Effectiveness of ST-Segment–Elevation Myocardial Infarction Regionalization Strategies (2010) (58)
- Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women. (1999) (58)
- Estimating the Prognosis of Hepatitis C Patients Infected by Transfusion in Canada between 1986 and 1990 (2004) (57)
- Economic evaluation of programs or interventions in the management of rheumatoid arthritis: defining a consensus-based reference case. (2003) (57)
- ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization (2012) (57)
- ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic (2019) (56)
- ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Impr (2011) (53)
- Assessing the comparative effectiveness of Tai Chi versus physical therapy for knee osteoarthritis: design and rationale for a randomized trial (2014) (53)
- Who should be screened for HIV infection? A cost-effectiveness analysis. (1993) (52)
- Risk-Targeted Lung Cancer Screening (2018) (50)
- Simulation of hepatitis C based on a mandatory reporting system (2002) (49)
- CAPriCORN: Chicago Area Patient-Centered Outcomes Research Network (2014) (49)
- Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement. (2022) (48)
- Isoniazid for the tuberculin reactor: take it or leave it. (1988) (48)
- Direct angioplasty for acute myocardial infarction. A review of outcomes in clinical subsets. (1992) (48)
- Development and evaluation of a risk communication curriculum for medical students. (2014) (47)
- Analytic Choices in Economic Models of Treatments for Rheumatoid Arthritis: What Makes a Difference? (2005) (47)
- You're never too old (1992) (45)
- Differing Experiences with Pre‐Exposure Prophylaxis in Boston Among Lesbian, Gay, Bisexual, and Transgender Specialists and Generalists in Primary Care: Implications for Scale‐Up (2017) (44)
- Screening for Vitamin D Deficiency in Adults: US Preventive Services Task Force Recommendation Statement. (2021) (43)
- Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement. (2019) (42)
- Characterizing Approaches to Dialysis Decision Making with Older Adults: A Qualitative Study of Nephrologists. (2018) (42)
- Screening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement. (2019) (42)
- A Risk Prediction Index for Advanced Colorectal Neoplasia at Screening Colonoscopy (2015) (42)
- Primary Care Interventions for Prevention and Cessation of Tobacco Use in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. (2020) (42)
- Cost effectiveness of ribavirin/interferon alfa-2b after interferon relapse in chronic hepatitis C. (2000) (40)
- Cost-effectiveness of interferon alfa-2b with and without ribavirin as therapy for chronic hepatitis C in Sweden. (2001) (39)
- Application of Pediatric and Adult Guidelines for Treatment of Lipid Levels Among US Adolescents Transitioning to Young Adulthood. (2015) (37)
- The cost effectiveness of infliximab for severe treatment-resistant rheumatoid arthritis in the UK (2012) (37)
- Interventions to Prevent Child Maltreatment: US Preventive Services Task Force Recommendation Statement (2018) (37)
- Economics of chronic hepatitis B and hepatitis C. (2007) (36)
- Screening for Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: US Preventive Services Task Force Recommendation Statement. (2020) (36)
- Cost-effectiveness of anti-tumor necrosis factor agents. (2004) (36)
- Screening for Asymptomatic Carotid Artery Stenosis: US Preventive Services Task Force Recommendation Statement. (2021) (36)
- Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement. (2021) (34)
- A pragmatic and cost-effective strategy of a combination therapy of interferon alpha-2b and ribavirin for the treatment of chronic hepatitis C (2001) (34)
- A meta-analytic comparison of echocardiographic stressors (2005) (34)
- Interferon for hepatitis C virus in hemodialysis--an individual patient meta-analysis of factors associated with sustained virological response. (2009) (34)
- Pretreatment evaluation of chronic hepatitis C - Risks, benefits, and costs (1999) (33)
- The Influence of Influence Diagrams in Medicine (2005) (32)
- Cost-effectiveness of treatments for chronic hepatitis C. (1999) (30)
- Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. (2020) (30)
- Strategies for diagnosing and treating suspected acute bacterial sinusitis (2001) (30)
- Perceptions of Telehealth vs In-Person Visits Among Older Adults With Advanced Kidney Disease, Care Partners, and Clinicians (2021) (30)
- Screening for Gestational Diabetes: US Preventive Services Task Force Recommendation Statement. (2021) (30)
- Trends and Disparities in Cardiometabolic Health Among U.S. Adults, 1999-2018. (2022) (29)
- Trends in acute myocardial infarction hospitalizations: Are we seeing the whole picture? (2015) (29)
- Evaluation of technologies for identifying acute cardiac ischemia in emergency departments. (2000) (29)
- Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement. (2022) (28)
- Propensity scores in the presence of effect modification: A case study using the comparison of mortality on hemodialysis versus peritoneal dialysis (2010) (27)
- The Evidence Basis for the American College of Rheumatology Practice Guidelines (2018) (27)
- The economics of hepatitis C virus. (2006) (27)
- Screening for Hearing Loss in Older Adults: U.S. Preventive Services Task Force Recommendation Statement (2012) (27)
- Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: US Preventive Services Task Force Reaffirmation Recommendation Statement (2019) (26)
- Evidence Underlying KDIGO (Kidney Disease: Improving Global Outcomes) Guideline Recommendations: A Systematic Review. (2016) (25)
- Interstate Variation in the Burden of Fragility Fractures (2008) (25)
- ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 appropriate use criteria for multimodality imaging in the assessment of cardiac structure and function in nonvalvular heart disease: A report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic (2019) (25)
- Screening for Elevated Blood Lead Levels in Children and Pregnant Women: US Preventive Services Task Force Recommendation Statement (2019) (24)
- A geospatial analysis of emergency transport and inter-hospital transfer in ST-segment elevation myocardial infarction. (2008) (24)
- Behavioral Counseling Interventions for Healthy Weight and Weight Gain in Pregnancy: US Preventive Services Task Force Recommendation Statement. (2021) (24)
- Commentary: Fine-tuning Life-espectancy Calculations Using Markov Processes (1993) (24)
- Long-term viral negativity after interferon for chronic hepatitis C virus infection in hemodialysis. (2011) (24)
- Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium. (2002) (24)
- A cost-effectiveness analysis of subject recruitment strategies in the HIPAA era: results from a colorectal cancer screening adherence trial (2009) (23)
- Interferon treatment for chronic hepatitis B or C infection: costs and effectiveness. (1998) (22)
- Temporal lobe epilepsy surgery: What do patients want to know? (2011) (22)
- Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. (2022) (21)
- Behavioral Counseling Interventions to Prevent Sexually Transmitted Infections: US Preventive Services Task Force Recommendation Statement. (2020) (21)
- ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic (2019) (21)
- Screening for High Blood Pressure in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. (2020) (21)
- Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease. (2011) (20)
- Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement. (2022) (20)
- Cost-effectiveness of ribavirin plus interferon alpha-2b for either interferon relapsers or non-responders in chronic hepatitis C: a Japanese trial. (2004) (18)
- A Peripartum Neurologic Event: Shooting from the Hip (1988) (18)
- Actions to Transform US Preventive Services Task Force Methods to Mitigate Systemic Racism in Clinical Preventive Services. (2021) (18)
- Collaboration and Shared Decision-Making Between Patients and Clinicians in Preventive Health Care Decisions and US Preventive Services Task Force Recommendations. (2022) (18)
- How (should) physicians think?: a journey from behavioral economics to the bedside. (2010) (17)
- Developing Prediction Models for 30-Day Unplanned Readmission Among Children With Medical Complexity. (2019) (17)
- A Call for Open-Source Cost-Effectiveness Analysis (2017) (17)
- A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection (2019) (17)
- Cardiac Screening Prior to Stimulant Treatment of ADHD: A Survey of US-Based Pediatricians (2012) (17)
- Clinical Effectiveness and Cost Effectiveness of Tailoring Chronic Hepatitis C Treatment with Peginterferon Alpha-2b Plus Ribavirin to HCV Genotype and Early Viral Response (2012) (17)
- Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome (2020) (17)
- Cytomegalovirus immune globulin after liver transplantation: a cost‐effectiveness analysis 1 (2000) (17)
- Modeling and Simulation in the Context of Health Technology Assessment: Review of Existing Guidance, Future Research Needs, and Validity Assessment (2017) (16)
- Risk Stratification and Shared Decision Making for Colorectal Cancer Screening (2016) (16)
- Therapeutic controversy: Hormone replacement therapy--where are we going? (1999) (16)
- Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: US Preventive Services Task Force Recommendation Statement. (2022) (16)
- Using observational data to estimate prognosis: an example using a coronary artery disease registry (2001) (16)
- Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon α-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany (2005) (16)
- All dysuria is local (2004) (16)
- Do the benefits of varicella vaccination outweigh the long-term risks? A decision-analytic model for policymakers and pediatricians. (2002) (15)
- Clinical problem-solving. A little math helps the medicine go down. (1999) (15)
- Patient Variability Seldom Assessed in Cost-effectiveness Studies (2018) (15)
- Screening and Interventions to Prevent Dental Caries in Children Younger Than 5 Years: US Preventive Services Task Force Recommendation Statement. (2021) (14)
- [Health economics of chronic infectious diseases: the example of hepatitis C]. (2006) (13)
- “We Make the Path by Walking It”: Building an Academic Community Partnership With Boston Chinatown (2014) (13)
- Mindfulness Is Associated With Treatment Response From Nonpharmacologic Exercise Interventions in Knee Osteoarthritis. (2017) (13)
- Recent national trends in acute myocardial infarction hospitalizations in Medicare: shrinking declines and growing disparities. (2015) (12)
- Screening for Eating Disorders in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. (2022) (12)
- Evaluating reporting and process quality of publications on UNHS: a systematic review of programmes (2015) (12)
- Economic analysis of nutrition interventions for chronic disease prevention: methods, research, and policy. (2011) (12)
- Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countries (2014) (12)
- Advance Care Planning in Older Adults with CKD: Patient, Care Partner, and Clinician Perspectives (2021) (12)
- Can Economic Model Transparency Improve Provider Interpretation of Cost-Effectiveness Analysis? A Response. (2017) (12)
- Is it influenza or anthrax? A decision analytic approach to the treatment of patients with influenza-like illnesses. (2004) (12)
- A 76-year-old woman with cardiac and renal failure and gastrointestinal bleeding (1998) (11)
- Advance Care Planning Among Older Adults With Advanced Non–Dialysis-Dependent CKD and Their Care Partners: Perceptions Versus Reality? (2020) (11)
- Quality of life and cost-effectiveness of anti-HCV therapy in HIV-infected patients. (2006) (11)
- Using observational data to estimate prognosis: an example using a coronary artery disease registry. (2001) (10)
- Quantifying the benefit of early living-donor renal transplantation with a simulation model of the Dutch renal replacement therapy population. (2012) (10)
- Variations in Physician Attitudes Regarding ADHD and Their Association With Prescribing Practices (2015) (10)
- Cost Effectiveness of Nutrition Policies on Processed Meat: Implications for Cancer Burden in the U.S. (2019) (10)
- Primary Care-Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults: US Preventive Services Task Force Recommendation Statement. (2020) (10)
- All dysuria is local. A cost-effectiveness model for designing site-specific management algorithms. (2004) (10)
- Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: US Preventive Services Task Force Recommendation Statement. (2022) (10)
- HEPATITIS Cost effectiveness of peginterferon α2 b plus ribavirin versus interferon α2 b plus ribavirin for initial treatment of chronic hepatitis C (2003) (9)
- An Evidence Review of Low-Value Care Recommendations: Inconsistency and Lack of Economic Evidence Considered (2021) (9)
- Health Policy and Cost-Effectiveness Analysis: Yes We Can. Yes We Must. (2009) (9)
- Recommendations for the Conduct and Reporting of Modeling and Simulation Studies in Health Technology Assessment (2016) (9)
- Sex work, injection drug use, and abscesses: Associations in women, but not men. (2018) (9)
- Differential response of placebo treatments in osteoarthritis trials: a systematic review and network meta-analysis (2014) (9)
- Effects of Tai Chi versus Physical Therapy on Mindfulness in Knee Osteoarthritis (2017) (9)
- The Utility of Thresholds and the Threshold Utility (1987) (8)
- Screening for Anxiety in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. (2022) (8)
- Epilepsy Surgery for Pharmacoresistant Temporal Lobe Epilepsy (2008) (8)
- Validating a Markov Model of Treatment for Hepatitis C Virus-related Hepatocellular Carcinoma (2008) (8)
- Screening for Syphilis Infection in Nonpregnant Adolescents and Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement. (2022) (8)
- Antiviral treatment initiation costs in chronic hepatitis C. (2005) (7)
- Numeracy and framing bias in epilepsy (2011) (7)
- Postexposure treatment of HIV. (1997) (7)
- Guidance for the Conduct and Reporting of Modeling and Simulation Studies in the Context of Health Technology Assessment (2008) (7)
- Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. (2022) (7)
- Modeling therapeutic benefit in the midst of uncertainty (1996) (7)
- Impact of postmenopausal hormone therapy on cardiovascular events and cancer. Study's conclusions were incorrect. (1997) (7)
- Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. (2022) (7)
- A Review of Validation and Calibration Methods for Health Care Modeling and Simulation (2017) (6)
- Decision analysis for isoniazid preventive therapy: take it or leave it? (1988) (6)
- Future Research Needs for the Comparison of Percutaneous Coronary Interventions with Bypass Graft Surgery in Nonacute Coronary Artery Disease (2010) (6)
- Cost-Effectiveness of a National Sugar-Sweetened Beverage Tax to Reduce Cancer Burdens and Disparities in the United States (2020) (6)
- Propensity Score‐Based Methods in Comparative Effectiveness Research on Coronary Artery Disease (2018) (6)
- Survey of United States child and adolescent psychiatrists' cardiac screening practices prior to starting patients on stimulants. (2012) (6)
- Cost-effectiveness of peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C (2002) (6)
- Cost-Effective but Bad for Health? Hepatitis C Treatment, Moral Hazard, and Opportunity Cost. (2017) (6)
- Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction Models (2017) (6)
- The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial. (2018) (6)
- Combining Wireless Technology and Behavioral Economics to Engage Patients (WiBEEP) with cardiometabolic disease: a pilot study (2019) (6)
- Clinical decision analysis using microcomputers. A case of coexistent hepatocellular carcinoma and abdominal aortic aneurysm. (1986) (6)
- Targeted Incentive Programs For Lung Cancer Screening Can Improve Population Health And Economic Efficiency. (2019) (6)
- 552 Comparing the public health burden of chronic hepatitis C and HIV infection in United States (2003) (5)
- 3 : Decision-Making in Clinical Medicine (2017) (5)
- Pandemic Surge Models in the Time of Severe Acute Respiratory Syndrome Coronavirus-2: Wrong or Useful? (2020) (5)
- Systematic Appraisal of the American College of Rheumatology Clinical Practice Guidelines (2019) (5)
- Decision Making in Health and Medicine: Valuing outcomes (2014) (5)
- The cumulative incidence of dysphagia and dysphagia‐free survival in persons diagnosed with amyotrophic lateral sclerosis (2021) (4)
- “I’m not gonna be able to do anything about it, then what’s the point?”: A broad group of stakeholders identify barriers and facilitators to HCV testing in a Massachusetts jail (2021) (4)
- Whole-grain food intake among US adults, based on different definitions of whole-grain foods, NHANES 2003-2018. (2022) (4)
- Association of National Expansion of Insurance Coverage of Medically Tailored Meals With Estimated Hospitalizations and Health Care Expenditures in the US (2022) (4)
- Revascularization for Femoropopliteal Disease (2017) (4)
- Biases in Individualized Cost-effectiveness Analysis: Influence of Choices in Modeling Short-Term, Trial-Based, Mortality Risk Reduction and Post-Trial Life Expectancy (2017) (4)
- Validation of Food Compass with a healthy diet, cardiometabolic health, and mortality among U.S. adults, 1999–2018 (2022) (4)
- Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement. (2022) (4)
- Intra-articular corticosteroids may be a cost-effective strategy for short-term management of knee osteoarthritis (2015) (4)
- Cost-effectiveness of conservative and interventional treatment strategies in patients with intermittent claudication (1998) (4)
- Validation and calibration of structural models that combine information from multiple sources (2017) (4)
- Cost - Effectiueness of Streptokinase for Acute Myocardial Infarction (1994) (4)
- “Unspoken Questions”: A Qualitative Study of Rheumatologists’ Perspectives on the Clinical Implementation of Patient-reported Outcome Measures (2020) (3)
- Shared Decision-Making During Initial Diagnostic and Treatment Planning Visits for Children with Autism Spectrum Disorder (2021) (3)
- Active learning for efficiently training emulators of computationally expensive mathematical models (2018) (3)
- Preference-based quality-of-life values in patients with chronic hepatitis C: Results from the German hepatitis C quality-of-life study (2003) (3)
- A conceptual framework for rationalized and standardized Universal Newborn Hearing Screening (UNHS) programs (2016) (3)
- Interferon and ribavirin for patients with chronic hepatitis C who did not respond to previous IFN therapy: A meta-analysis of controlled and uncontrolled trials (2000) (3)
- A Call for Open-Source Cost-Effectiveness Analysis. (2018) (3)
- Evaluating rapid virological response reduces ribavirin and peginterferon alfa-2B treatment costs for chronic hepatitis C in the United Kingdom (2003) (3)
- Guidance For The Conduct And Reporting Of Modeling And Simulation In The Context Of Health Technology Assessment (2015) (3)
- Pharmacogenomics of hepatitis C and decision analysis: A glimpse into the future (2002) (3)
- Empirical use of causal inference methods to evaluate survival differences in a real‐world registry vs those found in randomized clinical trials (2020) (3)
- [522] COST-EFFECTIVENESS OF TELBIVUDINE VERSUS LAMIVUDINE FOR CHRONIC HEPATITIS B (2007) (3)
- Pretreatment Evaluation of Chronic Hepatitis C (2015) (3)
- Reducing US Cancer Burden and Disparities Through National and Targeted Food Price Policies (P04-101-19). (2019) (3)
- Presidential Reflections on the 25th Anniversary of the Society for Medical Decision Making (2004) (3)
- Screening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement. (2022) (3)
- DEALE-ing with Lung Cancer and Heart Failure (2005) (3)
- Heterogeneity and uncertainty (2014) (3)
- The isoniazid debate. (1991) (3)
- Treatment Decision Making for Older Kidney Patients during COVID-19 (2022) (3)
- Decision Making in Health and Medicine: Elements of decision making in health care (2014) (2)
- Response by de Ferranti et al to Letter Regarding Article, "Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)". (2016) (2)
- The use of patient-specific equipoise to support shared decision-making for clinical care and enrollment into clinical trials (2019) (2)
- Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Reaffirmation Recommendation Statement. (2023) (2)
- Comparative Effectiveness Research and the Psychology of Medical Practice (2012) (2)
- A Meta-Analysis Of Randomized Controlled Trials With Coronary Drug-Eluting Stents Compared With Bare-Metal Stents (2005) (2)
- Prospective economic evaluation of the costs for medications and nutraceuticals in knee osteoarthritis (2016) (2)
- Decision Making in Health and Medicine: Choosing the best treatment (2014) (2)
- Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement. (2022) (2)
- Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and Spending (2022) (2)
- PHP26 COST-EFFECTIVENESS OF SCREENING DONATED BLOOD WITH MINIPOOL NUCLEIC ACID TESTING (NAT) FOR HEPATITIS B VIRUS (HBV), HEPATITIS C VIRUS (HCV), AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) (2002) (2)
- Leveraging Cumulative Network Meta-analysis and Value of Information Analysis to Understand the Evolving Value of Medical Research (2019) (2)
- 56 Natural history of fibrosis in chronic hepatitis C (2003) (2)
- Screening for Intracranial Aneurysms in Coarctation of the Aorta (2020) (2)
- Emerging Therapies for COVID-19: The Value of Information From More Clinical Trials (2022) (2)
- The implications of using patient preferences (utilities) vs. health status on decision making and policy recommendations for patients with ulcerative colitis (1995) (2)
- Reply (2018) (2)
- When and How Are We Engaging Stakeholders in Health Care Research (2015) (2)
- Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement (2019) (2)
- Estimated Yield of Screening for Heterozygous Familial Hypercholesterolemia With and Without Genetic Testing in US Adults (2022) (2)
- Abstract 19656: What is the Prevalence of Familial Hypercholesterolemia in the US? (2014) (2)
- Decision Making in Health and Medicine: Multiple test results (2014) (1)
- Pediatric Lipid Screening and Treatment for Cardiovascular Disease Prevention: An Ounce or a Pound? (2013) (1)
- Hospital Care at Home: Better, Cheaper, Faster? (2019) (1)
- Approximate Bayesian Computation for an Explicit-Duration Hidden Markov Model of COVID-19 Hospital Trajectories (2021) (1)
- Annals On Call - Surge Modeling for COVID-19. (2020) (1)
- Forecasting COVID-19 Counts At A Single Hospital: A Hierarchical Bayesian Approach (2021) (1)
- Shared Decision Making Among Older Adults With Advanced CKD. (2022) (1)
- Is peginterferon alfa-2B plus ribavirin cost-effective for treating chronic hepatitis C in the United Kingdom? (2003) (1)
- 1037-142 Postsystolic shortening is consistently prevalent in nonviable myocardium in patients with acute myocardial infarction: Comparison with contrast-enhanced magnetic resonance imaging (2004) (1)
- Incident type 2 diabetes attributable to suboptimal diet in 184 countries (2023) (1)
- Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma. (2023) (1)
- Tai Chi versus physical therapy for knee osteoarthritis: a cost-effectiveness analysis (2018) (1)
- Myocardial Revascularization for Chronic Stable Angina (2020) (1)
- Stakeholder engagement in methodological research: Development of a clinical decision support tool (2020) (1)
- Cost-effectiveness of Nutrition Policies to Discourage Processed Meat Consumption: Implications for Cancer Burden in the United States (OR16-01-19). (2019) (1)
- Meta-analytic comparison of echocardiographic stressors (1998) (1)
- Targeting of the diabetes prevention program leads to substantial benefits when capacity is constrained (2021) (1)
- Surveillance in a Prospectively Followed Cohort of Patients with Barrett Esophagus in the Netherlands: A Cost-Effectiveness Analysis (2009) (1)
- Admitting What We Do Not Know in Rheumatologic Disease-The First Step Toward Learning More-Reply. (2018) (1)
- The influence of analytic time horizon and treatment management algorithms on the cost of peginterferon alfa-2b plus ribavirin therapy for chronic hepatitis C (2003) (1)
- 551 Projecting the prognosis of hepatic fibrosis in HIV-HCV co-infection (2003) (1)
- Effect of the 2012 US Preventive Services Task Force Recommendations on Prostate-Specific Antigen Screening in a Medicare Advantage Population (2022) (1)
- Cost-effectiveness Analysis of Nutrition Facts Added-Sugar Labeling and Obesity-Associated Cancer Rates in the US (2021) (1)
- What is the cost-effectiveness of menu calorie labelling on reducing obesity-associated cancer burdens? An economic evaluation of a federal policy intervention among 235 million adults in the USA (2023) (1)
- ISPOR-SMDM task force's recommendations for good modeling practices-reply to letter to the editor by Corro Ramos. (2013) (1)
- Evidence-Based Medicine, Pharmacogenetics, and Antiplatelet Therapy Decision Making for Acute Coronary Syndrome (2014) (1)
- Health Impact and Cost-Effectiveness of Sugar-Sweetened Beverage Taxes for Reducing Cancer Burden in the United States (P22-010-19). (2019) (1)
- PAO8: THE COST-EFFECTIVENESS OF INFLIXIMAB FOR SEVERE RHEUMATOID ARTHRITIS (2001) (1)
- State-Level Variation In Low-Value Care For Commercially Insured And Medicare Advantage Populations. (2022) (1)
- Figure 2, Star graph of explicit ranking of six subpopulations by key informants (2010) (0)
- Abstract 15395: Estimating Coronary Heart Disease Morbidity and Mortality From Heterozygous Familial Hypercholesterolemia in the United States (2015) (0)
- Comparative Effectiveness of Adolescent Lipid Screening and Treatment Strategies (2018) (0)
- Survivor Costs in Cost-Effectiveness Analysis (2006) (0)
- CONCURRENT SESSION 51: LIVER ALLOCATION AND DONATION (2006) (0)
- Cost-effectiveness of Noninvasive Testing for Osteomyelitis-Reply (1995) (0)
- Stanley in Asymptomatic Children : A Meta-analysis Electrocardiogram Screening for Disorders That Cause Sudden Cardiac Death (2012) (0)
- The Costs and Benefits of Targeted Screening for Causes of Sudden Cardiac Death in Children and Adolescents Running title : (2012) (0)
- Abstract 18575: Comparative Effectiveness of Adolescent Cholesterol Screening and Treatment Strategies (2017) (0)
- Tu1089 Optimal Imaging for the Diagnosis of Acute Appendicitis in Adults, Children and Pregnant Women: A Decision Analysis (2015) (0)
- 3209 Hepatitis C Virus Linked To Increased Mortality in Inmates Who Are Hospitalized (2019) (0)
- Integrating Analytical Methods to Improve Comparative Effectiveness Research (2019) (0)
- Figure 3, Expected value of perfect information for groups of parameters over a range of cost-effectiveness thresholds (2010) (0)
- The Value of Risk-Stratified Information in the National Lung Cancer Screening Trial. (2014) (0)
- Health and Economic Impacts of a Sugar-Sweetened Beverage Warning Label in the US: A Micro-Simulation Study (2020) (0)
- Decision Making in Health and Medicine: Estimation, calibration, and validation (2014) (0)
- Appendix Figure D13, Graph of EVPPI for future research comparing DES, BMS and CABG for different groups of parameters over a wide range of willingness to pay for the model representing elderly patients (2010) (0)
- The economic impact of treatment management strategies in antiviral therapy of chronic hepatitis C (2015) (0)
- Appendix Figure D4, Tornado graph of cost-effectiveness analysis, comparing BMS with CABG in the typical RCT population (2010) (0)
- Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement. (2023) (0)
- List 2, Interim expanded list of evidence gaps (2010) (0)
- Decision Making in Health and Medicine: Constrained resources (2014) (0)
- HP2 THE IMPACT OF TREATMENT MANAGEMENT ALGORITHMS AND EVALUATED TIME HORIZON ON ANTIVIRAL TREATMENT COSTS IN CHRONIC HEPATITIS C (2003) (0)
- Diagnostic Strategies for Breast Cancer: Optimizing the Tradeoffs. (1999) (0)
- Cost-Effectiveness of the FDA Menu Labeling to Reduce Obesity-Associated Cancer Burden in the United States (2020) (0)
- IN4 POPULATION-BASED EVALUATION OF FUTURE BURDEN OF DISEASE AND COSTS RELATED TO CHRONIC HEPATITIS C AND ANTIVIRAL TREATMENT STRATEGIES (2004) (0)
- Appendix Table B2, Ongoing studies comparing PCI vs. CABG (from clinicaltrials.gov) (2010) (0)
- Search Prioritization Tools (2010) (0)
- Decision Making in Health and Medicine: Deciding when to test (2014) (0)
- Systematic Review of Recommendations for the Conduct and Reporting of Health Care Modeling and Simulation Studies (2017) (0)
- Surveillance with colectomy for low grade dysplasia increases length and quality of life in ulcerative colitis patients and is cost-effective compared with common medical practices (1998) (0)
- Su1433 LOW CLINICAL SUCCESS RATES AND HIGH COMPLICATION RATES IN PATIENTS UNDERGOING PERCUTANEOUS TRANSHEPATIC BILIARY DRAINAGE AFTER FAILED ERCP: RESULTS OF A LARGE TERTIARY CENTER (2018) (0)
- DIALYSIS DECISION-MAKING WITH ELDERLY PATIENTS: A QUALITATIVE STUDY OF NEPHROLOGISTS (2018) (0)
- Objectives To review the reliability of radiological diagnosis and need of regular scans for giant liver haemangioma, in terms of long-term outcome and management options. (2007) (0)
- Decision Making in Health and Medicine: Recurring events (2014) (0)
- S1012 Viral Kinetics and Duration of Hepatitis C Therapy for Genotypes 2 and 3: A Meta-Analysis (2008) (0)
- Periodic Liver Biopsy for Mild Hepatitis C (2001) (0)
- Medical Intoriatics Clinical Decision Analysis Using Microcomputers A Case of Coexistent Hepatocellular Carcinoma and Abominal Aortic Aneurysm Clinical decision analysis using microcomputers-A case of coexistent hepatocellular carcinoma and abdominal aortic aneurysm, In Medical informatics (2005) (0)
- Cost-Effectiveness of the FDA Added Sugar Labeling to Reduce Cancer Burden in the United States (OR28-03-19). (2019) (0)
- Observer Risk Communication Process and Content Measures (2017) (0)
- Abstract 17652: Application of Pediatric and Adult Lipid Treatment Guidelines to U.S. Adolescents Transitioning to Young Adulthood (2014) (0)
- Appendix Figure D14, Tornado graph of decision analysis, comparing PCI with CABG in the model representing diabetic patients (2010) (0)
- Appendix Figure D7, Graph of EVPPI for future research comparing DES, BMS and CABG for different groups of parameters over a wide range of willingness to pay for the base case scenario in the typical RCT population (2010) (0)
- Cross-genotype hepatitis C virus (HCV)-specific cytotoxic T lymphocyte (CTL) activity in the liver in chronic hepatitis C (1995) (0)
- DOES ELIGIBILITY FOR RANDOMIZED CONTROLLED TRIALS OF CORONARY REVASCULARIZATION AFFECT PATIENT CHARACTERISTICS IN OBSERVATIONAL DATA (2016) (0)
- INTERFERON FOR CHRONIC HEPTITIS B. AUTHORS' REPLY (1996) (0)
- PIN6 CLINICAL EFFECTIVENESS AND COST-EFFECTIVENESS OF ANTIVIRAL COMBINATION THERAPY WITH PEGINTERFERON ALFA-2B AND RIBAVIRIN FOR CHRONIC HEPATITIS C ADMINISTERED ACCORDING TO THE NEW GENOTYPESPECIFIC GUIDELINES (2004) (0)
- Appendix Table D1, Data sources for model parameters (2010) (0)
- ACHIEVING CHOLESTEROL GOALS IN PATIENTS WITH DIABETES: A FACTORIAL RANDOMIZED TRIAL OF FINANCIAL INCENTIVES AND PATIENT-CENTERED DECISION AID (2016) (0)
- Economic Considerations in Hepatology (2008) (0)
- in Asymptomatic Children: A Meta-analysis Electrocardiogram Screening for Disorders That Cause Sudden Cardiac Death (2012) (0)
- 3 – Principles of health economics and application to rheumatic disorders (2015) (0)
- Table 4, Prioritized research designs to address future research needs when studying the comparative effectiveness of PCI and CABG (2010) (0)
- Direct Angioplasty for Acute Myocardial Infarction (2020) (0)
- O.037 Prediction of HCV-related morbidity and mortality burden in France using the back-calculation method (2006) (0)
- Final report: Part 6 – Costs and Cost effectiveness of Interventions (2002) (0)
- 515 Cost-effectiveness of peginterferon plus ribavirin in a real-world population of patients with chronic hepatitis C and associated comorbidities (2004) (0)
- Decision Tool--a graphical user interface for generic Markov models. (1994) (0)
- Appendix Figure D3, Tornado graph of decision analysis, comparing DES with CABG in the typical RCT population (2010) (0)
- Appendix Table D3, Parameter estimates and distributions fit for probabilistic sensitivity analysis (2010) (0)
- Cost-effectiveness of treating hepatitis C in injecting drug users (2002) (0)
- Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement. (2023) (0)
- Methods and Results of Quantitative Analyses (2010) (0)
- 20-Year Public Health Predictions for Chronic Hepatitis C-Related Morbidity and Mortality–A GEHMO Simulation (2004) (0)
- 3385 TARGETING DIABETES PREVENTION PROGRAMS: INDIVIDUAL RISK-BASED HEALTH ECONOMIC ANALYSIS (2019) (0)
- Reply (2016) (0)
- Table 1, Research gaps and proposals for future research from the Stanford CER (2010) (0)
- Effects of Tai Chi versus Physical Therapy on Mindfulness in Knee Osteoarthritis (2017) (0)
- S1011 Pre-Transplant Antiviral Treatment of Hepatitis C with Decompensated Cirrhosis: A Systematic Review of Risks and Benefits (2008) (0)
- List 1, Initial list of evidence gaps (2010) (0)
- Appendix Figure D12, EVPI over willingness to pay for future research comparing DES, BMS and CABG for the model representing elderly patients (2010) (0)
- List 3, Pruned (final) list of important evidence gaps (2010) (0)
- Preventing Perinatal Transmission of Hepatitis B Necessitates Consideration of Antiviral Treatment in Pregnancy (2018) (0)
- Figure 3, Diagram of the modeling process (2017) (0)
- PMD34 ANALYTIC CHOICES IN ECONOMIC MODELS OF TREATMENTS FOR RHEUMATOID ARTHRITIS: WHAT MAKES A DIFFERENCE? (2003) (0)
- How Should the Epidemiology of Acute Hepatitis C and Opioid Use Affect Health Policy Decision-Making? (2018) (0)
- Contents Volume 21 2005 (2005) (0)
- Table B4, Criteria to qualitatively rank future research needs (2010) (0)
- Book Review Developing Clinical Problem-Solving Skills: A guide to more effective diagnosis and treatment By Howard S. Barrows and Garfield C. Pickell. 226 pp. New York, W.W. Norton, 1991. $17.95. ISBN 0–393–71010–6 . (1992) (0)
- Brief Introduction to Clinical Reasoning Clinical Expertise Defining (2017) (0)
- Best Practices in Global Academic Exchange: Lessons From an Interprofessional Collaborative Relationship With China (2019) (0)
- Abstract 18387: Applicability of Randomized Controlled Trials for Coronary Revascularization for Angina to Real World Academic Practice (2017) (0)
- Appendix Figure D15, Tornado graph of cost-effectiveness analysis, comparing PCI with CABG in the model representing diabetic patients (2010) (0)
- Cost-Effectiveness Analysis of Combination Therapy with Peginterferon and Ribavirin for Patients with Chronic Hepatitis C and Associated Diseases in the German Health Care Context (2004) (0)
- Abstract 2909: Prophylactic Extraction versus Continued Surveillance for the Fidelis Lead: A Decision Analysis (2009) (0)
- Appendix Figure D6, EVPI over willingness to pay for future research comparing DES, BMS and CABG for the typical RCT population (2010) (0)
- 722 Comparative Effectiveness of Telaprevir Versus Boceprevir for Genotype 1 Chronic Hepatitis C: An Indirect Pairwise Meta-Analysis (2013) (0)
- Decision Making in Health and Medicine: Psychology of judgment and choice (2014) (0)
- Understanding Treatment Decisions for Hodgkin Lymphoma: A Qualitative Study (2022) (0)
- WOULD OBSERVATIONAL DATA HAVE PREDICTED RESULTS FOUND IN RANDOMIZED CONTROLLED TRIALS OF CORONARY REVASCULARIZATION (2010) (0)
- Appendix Figure D16, EVPI over willingness to pay for future research comparing PCI and CABG for the model representing diabetic patients (2010) (0)
- Update on Current Epidemiologic Trends in Hepatitis C (2011) (0)
- PIN24 Potential Costs Associated with New Direct Acting Antiviral (DAAs) Therapy for Untreated Chronic Hepatitis C Genotype 1 Infection in the Veterans Health Administration (2011) (0)
- Facilitating Patient-Specific Decisions Regarding Hormone Replacement Therapy-Reply (1997) (0)
- Developing Software to Predict Patient Responses to Knee Osteoarthritis Treatments and to Identify Patients for Possible Enrollment in Randomized Controlled Trials (2019) (0)
- Does health-related quality of life reflect disease severity in chronic hepatitis C patients? (2002) (0)
- Appendix Figure B1, Search flow (2010) (0)
- Appendix Table D2, Calculation of cost of revascularization (2010) (0)
- Review of Guidance from Health Technology Assessment Organizations (2017) (0)
- Appendix Figure D1, Markov model structure for the CABG arm (2010) (0)
- Developing Criteria for Health Economic Quality Evaluation (CHEQUE) Tool. (2023) (0)
- Decision Making in Health and Medicine: Interpreting diagnostic information (2014) (0)
- A Stressful Situation (2019) (0)
- Economic burden of medications and nutraceuticals in knee osteoarthritis (2015) (0)
- Table 2, Candidate study designs for addressing different types of research needs (2010) (0)
- Interferon for Chronic Hepatitis B (1996) (0)
- 730 Hepatitis B Virus Reactivation During Chemotherapy for Solid Malignancies: A Systematic Review and Meta-Analysis (2015) (0)
- 299. “Where the Rubber Meets the Road”: Stakeholders’ Perspectives about the Current State of HCV Care Delivery in Massachusetts Jails (2019) (0)
- Herpes Zoster Infection in Patients With Inflammatory Bowel Disease: A Cost-Effectiveness Model of Vaccination Strategies: 666 (2017) (0)
- 4129 Understanding Treatment Preferences for Hodgkin Lymphoma (HL) among Physicians, Patients and Caregivers (2020) (0)
- UT4 PATIENT-DERIVED UTILITY ESTMATES OF CHRONIC HEPATITIS C BASED ON EQ-5D AND RS SCORES (2002) (0)
- Abstract 16268: Cost-Effectiveness Analysis for Prophylactic Electrophysiology Studies and Ablation in Asymptomatic Pediatric Wolff-Parkinson-White Syndrome (2011) (0)
- PIN34 INITIAL ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS C:A GERMAN HEALTH TECHNOLOGY ASSESSMENT AND DECISION ANALYSIS (2002) (0)
- Regional variation and the cost-effectiveness of surveillance of patients with barrett's esophagus (1995) (0)
- Figure 4, Power calculations for superiority RCTs for various 5-year primary event rates in the comparator arm (2010) (0)
- Strategies for Individualizing Patient Decisions About Hormone Therapy (1999) (0)
- Appendix Table B3, Characteristics of patients who underwent PCI or CABG in selected large clinical registries (2010) (0)
- Decision Making in Health and Medicine: Finding and summarizing the evidence (2014) (0)
- Prognostic/Clinical Prediction Models: Using Observational Data to Estimate Prognosis: An Example Using a Coronary Artery Disease Registry (2005) (0)
- AN OVERVIEW OF STATISTICAL METHODS FOR META-ANALYSES COMBINING INDIVIDUAL PARTICIPANT DATA AND AGGREGATE DATA (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With John B Wong?
John B Wong is affiliated with the following schools:
